![Instructions for Use Neulasta (nu-las-tah) (pegfilgrastim) Injection, for subcutaneous use Single-Dose Prefilled Syringe Instructions for Use Neulasta (nu-las-tah) (pegfilgrastim) Injection, for subcutaneous use Single-Dose Prefilled Syringe](https://www.pi.amgen.com/-/media/Project/Amgen/Repository/pi-amgen-com/ifu/nuelasta/pfs/assets/img/neulasta_instructions_img.png)
Instructions for Use Neulasta (nu-las-tah) (pegfilgrastim) Injection, for subcutaneous use Single-Dose Prefilled Syringe
![Fresenius Kabi Introduces Glycopyrrolate Injection, USP Simplist® Prefilled Syringes in 0.2 mg per 1 mL and 0.4 mg per 2 mL Presentations | BioSpace Fresenius Kabi Introduces Glycopyrrolate Injection, USP Simplist® Prefilled Syringes in 0.2 mg per 1 mL and 0.4 mg per 2 mL Presentations | BioSpace](https://mms.businesswire.com/media/20190429005618/en/718716/4/Glycopyrrolate_Syringes_Group.jpg)
Fresenius Kabi Introduces Glycopyrrolate Injection, USP Simplist® Prefilled Syringes in 0.2 mg per 1 mL and 0.4 mg per 2 mL Presentations | BioSpace
![Fresenius Kabi Introduces Glycopyrrolate Injection, USP Simplist® Prefilled Syringes in 0.2 mg per 1 mL and 0.4 mg per 2 mL Presentations - Fresenius Kabi USA Fresenius Kabi Introduces Glycopyrrolate Injection, USP Simplist® Prefilled Syringes in 0.2 mg per 1 mL and 0.4 mg per 2 mL Presentations - Fresenius Kabi USA](https://www.fresenius-kabi.com/us/images/Glycopyrrolate_Syringes_Group_rdax_694x694.jpg)
Fresenius Kabi Introduces Glycopyrrolate Injection, USP Simplist® Prefilled Syringes in 0.2 mg per 1 mL and 0.4 mg per 2 mL Presentations - Fresenius Kabi USA
![HYDROMORPHONE (NEXJECT) Instructions For Use (hydromorphone hydrochloride injection, USP) | Pfizer Medical Information - US HYDROMORPHONE (NEXJECT) Instructions For Use (hydromorphone hydrochloride injection, USP) | Pfizer Medical Information - US](https://www.pfizermedicalinformation.com/sites/default/files/spl-images/14580/hydromorphone-03.jpg)
HYDROMORPHONE (NEXJECT) Instructions For Use (hydromorphone hydrochloride injection, USP) | Pfizer Medical Information - US
![Prefilled syringes: Key considerations for ready-to-use drug administration - Pharmaceutical Technology Prefilled syringes: Key considerations for ready-to-use drug administration - Pharmaceutical Technology](https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2021/05/shutterstock_1140468401.jpg)
Prefilled syringes: Key considerations for ready-to-use drug administration - Pharmaceutical Technology
![Fresenius Kabi Introduces Simplist™ Heparin Sodium Injection, USP, Expanding Portfolio of Ready-to-Administer Prefilled Syringes | Business Wire Fresenius Kabi Introduces Simplist™ Heparin Sodium Injection, USP, Expanding Portfolio of Ready-to-Administer Prefilled Syringes | Business Wire](https://mms.businesswire.com/media/20161215005106/en/560215/5/Simplist_Heparin_FK_NDC-76045-108-10_for_banner.jpg)
Fresenius Kabi Introduces Simplist™ Heparin Sodium Injection, USP, Expanding Portfolio of Ready-to-Administer Prefilled Syringes | Business Wire
![Epinephrine autoinjection alternative pre-filled syringes: A Simple Inexpensive Solution | Donald Altman M.D. Epinephrine autoinjection alternative pre-filled syringes: A Simple Inexpensive Solution | Donald Altman M.D.](http://altmanmd.com/wp-content/uploads/2016/09/epi-diagram.jpg)